|
|
Volumn 6, Issue 5, 2007, Pages 341-342
|
|
Therapies for Alzheimer's disease
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
3 (2,4 DIMETHOXYBENZYLIDENE)ANABASEINE;
ACC 001;
ALZHEIMER DISEASE VACCINE;
AMYLOID BETA PROTEIN;
AMYLOID BETA PROTEIN ANTIBODY;
ATG Z 1;
BAPINEUZUMAB;
BETA SECRETASE INHIBITOR;
CHOLINESTERASE INHIBITOR;
DONEPEZIL;
E 2012;
GALANTAMINE;
GAMMA SECRETASE INHIBITOR;
HOMOTAURINE;
LECOZOTAN;
LY 2062430;
LY 450139;
MEMANTINE;
MK 0752;
MUSCARINIC M1 RECEPTOR AGONIST;
NGX 267;
NOOTROPIC AGENT;
PLACEBO;
PRX 03410;
RIVASTIGMINE;
RN 1219;
SEROTONIN 4 AGONIST;
TACRINE;
TARENFLURBIL;
UNCLASSIFIED DRUG;
UNINDEXED DRUG;
XALIPRODEN;
ACTIVE IMMUNIZATION;
ALZHEIMER DISEASE;
ARTICLE;
CLINICAL TRIAL;
DISEASE COURSE;
DRUG APPROVAL;
DRUG CHOICE;
DRUG EFFICACY;
DRUG MARKETING;
DRUG MECHANISM;
DRUG RESEARCH;
DRUG SAFETY;
DRUG TARGETING;
HUMAN;
MENINGOENCEPHALITIS;
NEUROFIBRILLARY TANGLE;
PASSIVE IMMUNIZATION;
PATENT;
PRIORITY JOURNAL;
SENILE PLAQUE;
SYMPTOM;
TREATMENT OUTCOME;
ALZHEIMER DISEASE;
ALZHEIMER VACCINES;
AMYLOID BETA-PROTEIN;
AMYLOID PRECURSOR PROTEIN SECRETASES;
CHOLINESTERASE INHIBITORS;
CLINICAL TRIALS;
EXCITATORY AMINO ACID ANTAGONISTS;
GABA AGONISTS;
HUMANS;
IMMUNIZATION;
MEMANTINE;
RECEPTORS, N-METHYL-D-ASPARTATE;
TAURINE;
|
|
EID: 34247876141
PISSN: 14741776
EISSN: 14741784
Source Type: Journal
DOI: 10.1038/nrd2314 Document Type: Article |
|
Times cited : (193)
|
|
References (3)
|
